Glioblastoma Multiforme Research Solutions

Watch our video to learn how our digital solutions and clinical science expertise can advance the development of new therapeutic options for glioblastoma multiforme (GBM) by helping to:

• Integrate patient quality-of-life and functional status measures to accurately assess the impact of disease and treatment symptoms
• Convey protocol requirements concisely so study teams can capture truly informed consent
• Train and monitor raters to administer/score assessments accurately and consistently
• Manage complex randomization, multiple treatment arms and cohorts, and variable dosing schemes common in oncology trials